Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
Frontiers in Pharmacology · 28.11.2024 · 15
DOI: 10.3389/fphar.2024.1432480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.11.2024. Verfasst von Xiao Hong und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Alcohol-related liver disease (ALD) is a major cause of morbidity and mortality worldwide. It encompasses conditions such as fatty liver, alcoholic hepatitis, chronic hepatitis with liver fibrosis or cirrhosis, and hepatocellular carcinoma. Numerous recent studies have demonstrated the critical role of oxidative stress, abnormal lipid metabolism, endoplasmic reticulum stress, various forms of cell death (including apoptosis, necroptosis, and ferroptosis), intestinal microbiota dysbiosis, liver immune response, cell autophagy, and epigenetic abnormalities in the pathogenesis of ALD. Currently, abstinence, corticosteroids, and nutritional therapy are the traditional therapeutic interventions for ALD. Emerging therapies for ALD mainly include the blockade of inflammatory pathways, the promotion of liver regeneration, and the restoration of normal microbiota. Summarizing the advances in animal models of ALD will facilitate a more systematic investigation of the pathogenesis of ALD and the exploration of therapeutic targets. This review summarizes the latest insight into the pathogenesis and molecular mechanisms of ALD, as well as the pros and cons of ALD rodent models, providing a basis for further research on therapeutic strategies for ALD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
- The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
- The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Medicine, Hangzhou Normal University, Hangzhou, China.
- The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hong, X., Huang, S., Jiang, H., Ma, Q., Qiu, J., Luo, Q., Cao, C., Xu, Y., Chen, F., Chen, Y., Sun, C., Fu, H., Liu, Y., Li, C., Chen, F., & Qiu, P. (2024). Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1432480
Vancouver
Hong X, Huang S, Jiang H, Ma Q, Qiu J, Luo Q, et al. Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1432480
BibTeX
@article{Hong2024,
author = {Hong, Xiao and Huang, Shuo and Jiang, He and Ma, Qing and Qiu, Jiang and Luo, Qihan and Cao, Chunlu and Xu, Yiyang and Chen, Fuzhe and Chen, Yufan and Sun, Chunfeng and Fu, Haozhe and Liu, Yiming and Li, Changyu and Chen, Fangming and Qiu, Ping},
title = {Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1432480}
}
EUVIMED